STAT3 and intrahepatic cholangiocarcinoma: Using two primary cells derived from FISSs (FISS-10 and FISS-14) showing consistent ICC and IHC patterns as their parental FFPE tissues, a dose-dependent inhibitory effect on the growth and migration ability of FISS cells after treatment with the STAT3 inhibitor LLL12 was confirmed.